STAT

FEBRUARY 26, 2024

In a first-in-the-nation move, a state board voted to create a payment limit for a widely prescribed Amgen drug used to treat arthritis, a step that may usher in a new era in which state governments take more aggressive action to control the cost of prescription medicines.

Drug Pricing 281

Drug Pricing 281

STAT

NOVEMBER 14, 2022

In this video, we chat with health policy and drug pricing researcher Hussain Lalani; Julia Joung, a molecular biologist developing genetic screening technologies; and Avinash Manjula Basavanna, who researches engineered living materials and has developed a printable ink made from bacteria.

Drug Pricing 203

Drug Pricing 203

Drug Channels

FEBRUARY 7, 2022

Drug Pricing Transparency Congress. Hybrid Event March 28-29, 2022 | Philadelphia, PA www.informaconnect.com/drug-pricing-transparency. Don’t miss the Drug Pricing Transparency Congress on March 28-29, 2022! Drug Channels, or any of its employees. Drug Channels, or any of its employees.

Drug Pricing 97

Drug Pricing 97

Express Pharma

NOVEMBER 27, 2024

Challenging market conditions, driven by drug pricing pressures, regulatory shifts, and geopolitical tensions, have reshaped the landscape, offering both hurdles and opportunities for contract manufacturing organisations (CMOs) to adapt and innovate amidst global generic shortages, reveals GlobalData.

Drug Pricing 105

Drug Pricing 105

STAT

FEBRUARY 17, 2023

The Inflation Reduction Act of 2022 , which includes provisions requiring Medicare to negotiate lower drug prices for some of the United States’ most costly drugs, marks the first time in decades that the pharmaceutical industry has lost a major policy battle. The industry’s latest red herring ?

Drug Pricing 246

Drug Pricing 246

Drug Channels

APRIL 4, 2025

It's time for Drug Channels annual examination of U.S. brand-name drug pricing. For 2024, average brand-name drugs list prices grew by only 2.3%. Whats more, after adjusting for overall inflation, brand-name drug net prices dropped for an unprecedented seventh consecutive year.

Drug Pricing 52

Drug Pricing 52

STAT

JANUARY 21, 2023

But by most financial measures, 2022 was a terrible, horrible, no-good year for biotech — here and everywhere else. And a new federal law to combat high drug prices sent a chill down the industry’s spine. And a new federal law to combat high drug prices sent a chill down the industry’s spine.

Drug Pricing 238

Drug Pricing 238

Drug Channels

JANUARY 4, 2023

Time for the Drug Channels annual reality check on drug pricing. For 2022, brand-name drugs’ net prices dropped for an unprecedented fifth consecutive year. What’s more, after adjusting for overall inflation, brand-name drug net prices plunged by almost 9%. d/b/a Drug Channels Institute.

Drug Pricing 98

Drug Pricing 98

Drug Channels

MARCH 31, 2023

Time for the Drug Channels annual reality check on drug pricing. For 2022, brand-name drugs’ net prices dropped for an unprecedented fifth consecutive year. What’s more, after adjusting for overall inflation, brand-name drug net prices plunged by almost 9%. d/b/a Drug Channels Institute.

Drug Pricing 97

Drug Pricing 97

Drug Channels

OCTOBER 4, 2023

When rebates and discounts were factored in, brand-name drug prices again declined—or grew slowly—in 2022. However, some companies had net price gains. For the eight companies with multiple years of data, the gross-to-net difference in price changes was the smallest gap in six years. d/b/a Drug Channels Institute.

Drug Pricing 98

Drug Pricing Pharmaceutical Manufacturing 98

Drug Channels

JUNE 13, 2023

When rebates and discounts were factored in, brand-name drug prices again declined—or grew slowly—in 2022. However, some companies had net price gains. For the eight companies with multiple years of data, the gross-to-net difference in price changes was the smallest gap in six years. See the second chart below.

Drug Pricing 98

Drug Pricing Pharmaceutical Manufacturing 98

Drug Channels

SEPTEMBER 24, 2023

Drug Channels has just obtained new details on the size of the 340B Drug Pricing Program. For 2022, discounted purchases under the 340B program reached a record $53.7 The difference between list prices and discounted 340B purchases also grew, to $52.3 Hospitals accounted for 87% of 340B purchases for 2022.

Drug Pricing 96

Drug Pricing Hospitals 96

Drug Channels

DECEMBER 15, 2023

Drug Channels has just obtained new details on the size of the 340B Drug Pricing Program. For 2022, discounted purchases under the 340B program reached a record $53.7 Hospitals accounted for 87% of 340B purchases for 2022. My topic #9 for 2024: The Battle Over 340B Gets Even Messier. billion —an astonishing $9.8

Drug Pricing 98

Drug Pricing Hospitals 98

Pharmaceutical Technology

DECEMBER 27, 2022

The healthcare industry saw its share of ups and downs in 2022. Along the way, mergers and acquisitions continued to happen, new drugs and devices got approved, and innovations in the clinical trial industry were introduced. The post Looking back at 2022: The top healthcare stories appeared first on Pharmaceutical Technology.

Vaccines 122

Vaccines Drug Development Drug Pricing 122

STAT

SEPTEMBER 6, 2023

29, Medicare released its highly anticipated list of 10 therapies for which it plans to establish a price by 2026.

Biosimilars 331

Biosimilars Drug Pricing 331

STAT

AUGUST 30, 2023

government’s initial approach to negotiating drug prices could discourage cheaper biosimilar versions of more complex pharmaceuticals that eat up a high portion of total Medicare spending , Bloomberg Law explains. Medicare picked its top 10 list based on total spending between June 1, 2022, and May 31, 2023.

Biosimilars 255

Biosimilars Drug Pricing 255

STAT

OCTOBER 2, 2024

The results generated considerable excitement since a daily pill is nearly 100% effective but compliance is spotty and there is a stigma attached to regularly taking a drug for HIV. But its impact on addressing an epidemic that, as of 2022, still led to more than 1 million new infections each year is uncertain.

Drug Pricing 318

Drug Pricing 318

Drug Channels

NOVEMBER 16, 2021

In Consolidation and Preferred Pharmacy Networks in 2022’s Medicare Part D Plans , I highlighted how those networks have hijacked the world of stand-alone Medicare Part D prescription drug plans (PDP) and become a major presence in Medicare Advantage prescription drug (MA-PD) plans. d/b/a Drug Channels Institute.

Drug Pricing 98

Drug Pricing 98

STAT

FEBRUARY 23, 2024

In a first-in-the-nation move, a state board voted to create a payment limit for a widely prescribed Amgen drug used to treat arthritis, a step that may usher in a new era in which state governments take more aggressive action to control the cost of prescription medicines.

Drug Pricing 320

Drug Pricing 320

PhRMA

JUNE 14, 2023

The 340B Drug Pricing Program has grown yet again , exceeding $100 billion in sales in 2022 when 340B-priced medicines are measured at wholesale acquisition cost. year-over-year in 2022, continuing a trend in which 340B sales have almost doubled since 2018, outpacing growth of the total U.S. drug market.

Drug Pricing 123

Drug Pricing 123

STAT

JUNE 14, 2024

The vote means the board will decide in a follow-up meeting whether to pursue an upper payment limit for the drug, which an affordability review found cost an average of roughly $47,000 per patient in 2022.

Drug Pricing 293

Drug Pricing 293

Drug Channels

FEBRUARY 22, 2022

On March 15, 2022, Drug Channels Institute will release The 2022 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. drug pricing, reimbursement, and dispensing system. Special preorder and launch pricing discounts will be valid through March 28, 2022.

Specialty Pharmacies 96

Specialty Pharmacies Drug Pricing Biosimilars Vaccines 96

Drug Channels

JUNE 22, 2022

See The GoodRx-Kroger Blowup: Spread Pricing, Pharmacy Margins, and the Future of Discount Cards. In the video below, I discuss how generic drug pricing and the rise of patient-paid, discount card prescriptions pose a risk to pharmacy benefit plans and the PBM business. d/b/a Drug Channels Institute.

Drug Pricing 75

Drug Pricing 75

Drug Channels

MARCH 15, 2022

I am pleased to announce our new 2022 Economic Report on U.S. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study Examines Consolidation and Vertical Integration of U.S. The 2022 Economic Report on U.S. Click to Enlarge].

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing Pharmaceutical Manufacturing Documentation 98

Drug Channels

MARCH 8, 2023

drug pricing, reimbursement, and dispensing system. prescription dispensing revenues for calendar year 2022. prescription dispensing revenues reached a record $548 billion in 2022. It’s the 14th edition of our popular and comprehensive examination of the entire U.S.

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing 98

Safe Biologics

JANUARY 1, 2023

drug distribution system Explain the effects of competition on drug pricing under provider-administered and patient-administered drugs. The paper was published in GaBI Journal, Volume 11, Year 2022, Issue 3. Read the full paper online here. Read more about the approval here. Read it Here.

Biosimilars 100

Biosimilars Drug Pricing 100

European Pharmaceutical Review

JUNE 24, 2022

2022 is probably the biggest year in EU pharmaceutical law that I have seen in 30 years. 2022 is undeniably a critical year for change in the pharmaceutical industry: for the first time in several decades, the European Union (EU)’s pharmaceutical legislation is up for review. Key areas of potential legislative change. Future outlook.

Compounding 105

Compounding Drug Development Drug Pricing Dosage 105

Drug Channels

JULY 12, 2022

Despite what you may have heard, pharmacy participation in the 340B Drug Pricing Program continues to thrive. Drug Channels Institute’s latest analysis reveals that an astonishing 32,000 pharmacy locations —more than half of the entire U.S. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Drug Pricing 98

Drug Pricing Hospitals 98

Drug Channels

NOVEMBER 15, 2021

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webinar: Drug Channels Outlook 2022. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. The Outlook 2022 marks our third annual outlook webinar. to 1:30 p.m.

Specialty Pharmacies 72

Specialty Pharmacies Drug Pricing Biosimilars 72

STAT

OCTOBER 8, 2024

The lawsuits follow an FDA announcement last week that Lilly determined its manufacturing capacity can meet “present and projected” national demand after a sustained shortage of the drug. from 1967 until 2022. ” A U.S.

Compounding 238

Compounding Compounding Pharmacies Vaccines Immunity 238

STAT

SEPTEMBER 15, 2022

Earlier this week, the Swiss agency conducted a dawn raid on Novartis headquarters in Basel, Switzerland, seeking information about efforts the company allegedly made to protect a drug for an unspecified skin treatment. billion in sales in the first half of 2022. Continue to STAT+ to read the full story…

Drug Pricing 246

Drug Pricing 246

STAT

DECEMBER 6, 2023

Beneficiaries with two or more of the costliest conditions — diabetes, heart failure, or chronic kidney disease — comprise just 10% of beneficiaries, according to the NIH’s Renal Data System 2022 Annual Data Report. Yet they account for 25% of total costs.

Diabetes 299

Diabetes Drug Pricing 299

STAT

OCTOBER 18, 2023

… Investors in biopharma companies, who lobbied vigorously — but unsuccessfully — against allowing Medicare to negotiate drug prices, are trying a new tactic to preserve their profits , The Boston Globe tells us.  Have a grand day, and drop us a line if you hear something juicy.

Drug Pricing 277

Drug Pricing 277

STAT

OCTOBER 2, 2024

Blue Shield of California struck an unusual deal to buy a lower-cost version of Humira directly from a manufacturer, bypassing the giant pharmacy benefit managers that normally determine which maker’s drug will go to tens of millions of Americans. And the reason is pricing.

Drug Pricing 236

Drug Pricing 236

STAT

DECEMBER 13, 2024

billion, the highest level since tracking of funding began in 2005 and 20% more than what was seen in 2022. Specifically, the amount spent on basic research, new treatments, vaccines, and diagnostics was $1.2

Pharmaceutical Companies 249

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Pricing 249

Drug Channels

JULY 28, 2022

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. Click here to see the original post from May 2022. Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers.

Drug Pricing 98

Drug Pricing Pharmaceutical Manufacturing 98

Pharmaceutical Technology

FEBRUARY 8, 2023

The 13 top players experienced significant growth over 2022 despite the decline in demand for COVID-19 vaccines and therapeutics, as well as uncertainty surrounding pricing due to the newly passed Inflation Reduction Act in the US. billion on Dec 31, 2022. Merck & Co. Merck & Co. billion to $281.3

Vaccines 78

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 78